Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglyceridesKatey J. Rayner, Kathryn J. Moore, Tathagat Dutta Ray et al.|Nature|2011Cited by 701
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosisKatey J. Rayner, Kathryn J. Moore, Frederick J. Sheedy et al.|Journal of Clinical Investigation|2011Cited by 686
Abstract 45: Antiatherosclerotic Effects of miR-33 Inhibition: Increased Reverse Cholesterol Transport and Alternative-Activation (M2) of MacrophagesKatey J. Rayner, Kathryn J. Moore, Frederick J. Sheedy et al.|Arteriosclerosis Thrombosis and Vascular Biology|2012Cited by 0